Procalcitonin: Inflammatory Biomarker for Assessing the Severity of Community-Acquired Pneumonia - A Clinical Observation in Geriatric Patients

被引：13

作者：

Heppner, H. J. ^{[1
]}

Bertsch, T. ^{[2
]}

Alber, B. ^{[2
]}

Esslinger, A. S. ^{[3
]}

Dragonas, C. ^{[1
]}

Bauer, J. M. ^{[1
]}

Sieber, C. C. ^{[1
]}

机构：

[1] Klinikum Nurnberg, Med Klin Akutgeriatrie 2, Lehrstuhl Innere Med Geriatrie, FAU Erlangen Nurnberg, Nurnberg, Germany

[2] Klinikum Nurnberg, Inst Klin Chem & Labs Med, Nurnberg, Germany

[3] Betriebswirtschaftliches Inst Wirtschafts & Sozia, Fak FAU Erlangen Nurnberg, Nurnberg, Germany

来源：

GERONTOLOGY | 2010年 / 56卷 / 04期

关键词：

Community-acquired pneumonia; Pneumonia; CURB; 65; Procalcitonin; RISK-FACTORS; VALIDATION; OUTCOMES;

D O I：

10.1159/000262285

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Community-acquired pneumonia is a common disease of the elderly and involves a high mortality risk. Demographic developments are creating new challenges for acute medical treatment strategies in geriatric patients with their underlying multimorbidity. In addition to the diagnostic parameters recorded on hospital admission, such as white cell count and C-reactive protein, procalcitonin, more than the risk scores CRB- and CURB-65 evaluated to date, appears to be a promising parameter for assessing the severity of pneumonia in elderly patients to allow early detection of severe courses and initiation of suitable treatment. The decisive factor is the dynamic course of the procalcitonin values over 3 consecutive days, as demonstrated in this case series. Copyright (C) 2009 S. Karger AG, Basel

引用

页码：385 / 389

页数：5

共 15 条

[1] Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].

Christ-Crain, M ;

Jaccard-Stolz, D ;

Bingisser, R ;

Gencay, MM ;

Huber, PR ;

Tamm, M ;

Müller, B .

LANCET, 2004, 363 (9409) :600-607

[2] Validation of predictive rules and indices of severity for community acquired pneumonia [J].

Ewig, S ;

de Roux, A ;

Bauer, T ;

García, E ;

Mensa, J ;

Niederman, M ;

Torres, A .

THORAX, 2004, 59 (05) :421-427

[3]

Fabel H., 1997, Intensivmedizin und Notfallmedizin, V34, P466, DOI 10.1007/s003900050074

[4] Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia [J].

Halm, EA ;

Fine, MJ ;

Kapoor, WN ;

Singer, DE ;

Marrie, TJ ;

Siu, AL .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (11) :1278-1284

[5] Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department [J].

Hausfater, Pierre ;

Juillien, Gaelle ;

Madonna-Py, Beatrice ;

Haroche, Julien ;

Bernard, Maguy ;

Riou, Bruno .

CRITICAL CARE, 2007, 11 (03)

[6] Inflammatory markers in SIRS, sepsis and septic shock [J].

Herzum, I. ;

Renz, H. .

CURRENT MEDICINAL CHEMISTRY, 2008, 15 (06) :581-587

[7]

HOFFKEN G, 2005, EPIDEMIOLOGIE DIAGNO

[8] Risk factors for community acquired pneumonia (CAP):: A systematic review [J].

Kohlhammer, Y ;

Schwartz, M ;

Raspe, H ;

Schäfer, T .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (08) :381-386

[9] A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation [J].

Levey, AS ;

Bosch, JP ;

Lewis, JB ;

Greene, T ;

Rogers, N ;

Roth, D .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :461-+

[10] Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study [J].

Lim, WS ;

van der Eerden, MM ;

Laing, R ;

Boersma, WG ;

Karalus, N ;

Town, GI ;

Lewis, SA ;

Macfarlane, JT .

THORAX, 2003, 58 (05) :377-382

← 1 2 →